ebook Munafa Stock Market Course + Intraday & FNO calls  

       

500087 announcements Cipla Ltd. announcements and dividends declared BSE

Cipla Ltd. Complete list of announcements declared & dividend announcements by Cipla Ltd. 500087

Cipla Ltd. 500087 listed on BSE and deals in

Announcements and dividends declared by Cipla Ltd. 500087

Cipla expects US business to draw support from upcoming product pipeline
Cipla reported a significant decline in its consolidated net profit for the second quarter of FY27. The company's North American revenue fell by 19% due to increased competition impacting sales of generic Revlimid. However, Cipla anticipates that its upcom
Announcement as on 27 October 2026

Market wrap: Bajaj Finance, Cipla, Nestle India, Eternal top gainers and losers on Nifty and Sensex on Thursday
Indian equity markets fell for a third consecutive session as weak global cues and sustained selling weighed on sentiment. The Nifty 50 declined 0.54% to 22,688, while the Sensex dropped 0.62% to 73,249.
Announcement as on 22 October 2026

Market wrap: Cipla, ONGC, HDFC Life, Bajaj Finance top gainers and losers on Nifty and Sensex on Thursday
Indian equities ended sharply lower, with the Nifty falling 1.64% and Sensex 1.67%, as rising bond yields and crude prices pressured sentiment. Broader indices declined, India VIX surged 22%, financial stocks led losses, and market breadth remained firmly
Announcement as on 24 September 2026

Cipla partners with Qilu to license, supply Keytruda biosimilar in US
Drug major Cipla Ltd on Thursday said its wholly owned subsidiary, Invagen Pharmaceuticals Inc, has entered into a strategic partnership with Qilu Pharmaceutical for the licensing and supply of a biosimilar to the cancer drug Keytruda in the United States.
Announcement as on 04 September 2026

Cipla, China's Qilu partner for US launch of Merck's Keytruda biosimilar
Cipla said its US unit has entered an exclusive partnership with China’s Qilu Pharmaceutical to license QL2107, a biosimilar of Merck’s cancer drug Keytruda. Qilu will handle development, approvals, manufacturing and supply, while Cipla USA will commercial
Announcement as on 04 September 2026

Announcements by Cipla Ltd. first page | Next page | Prev page |

500087 Cipla Ltd. current price & indicator signals

Moving Averages for Cipla Ltd.

  • 5Day Average: 1351.4
  • 12Day Average: 1336.1
  • 20Day Average: 1347.2
  • 50Day Average: 1381.68
  • 100Day Average: 1402.86
  • 150Day Average: 1368.23
  • 200Day Average: 1368.74

500087 Indicators & signals

Indicator MACD (12,26,9)

1345.55, 1354.78, -14.76
Indicator MACD is in negative zone

Indicator ADX (14)

11.88, 14.54, 18.46
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 56
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 500087 Cipla Ltd. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
29 Thu Oct 2026 1357.00 1347.25 to 1372.10 -0.22% 0.88 times
28 Wed Oct 2026 1360.00 1327.05 to 1368.00 0.74% 0.86 times
27 Tue Oct 2026 1350.00 1319.40 to 1372.45 -0.22% 2.15 times
26 Mon Oct 2026 1353.00 1332.00 to 1359.90 1.2% 1.04 times
23 Fri Oct 2026 1337.00 1313.55 to 1337.00 0.53% 0.89 times
22 Thu Oct 2026 1329.90 1296.00 to 1329.90 1.23% 0.34 times
21 Wed Oct 2026 1313.80 1308.55 to 1337.70 -1.29% 0.55 times
19 Mon Oct 2026 1331.00 1322.10 to 1337.80 0.45% 1.91 times
16 Fri Oct 2026 1325.00 1315.00 to 1336.65 -0.65% 0.97 times
15 Thu Oct 2026 1333.70 1311.20 to 1336.65 1.59% 0.74 times
14 Wed Oct 2026 1312.85 1303.60 to 1330.60 -1.29% 0.54 times
13 Tue Oct 2026 1330.00 1303.55 to 1330.00 1.24% 0.34 times

Videos related to: 500087 announcements Cipla Ltd. announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

500087 announcements Cipla Ltd. announcements and dividends declared BSE

 

Back to top